Stock YMAB Y-MABS THERAPEUTICS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Comparison Chart Y-mAbs Therapeutics, Inc.

Equities

YMAB

US9842411095

Real-time Estimate Cboe BZX
Other stock markets
 19:33:33 14/05/2024 BST 		5-day change 1st Jan Change
11.74 USD -3.69% Intraday chart for Y-mAbs Therapeutics, Inc. -31.44% +73.02%
05-08 Transcript : Y-mAbs Therapeutics, Inc., Q1 2024 Earnings Call, May 08, 2024
05-07 Earnings Flash (YMAB) Y-MABS THERAPEUTICS Posts Q1 Revenue $19.9M, vs. Street Est of $22.2M MT
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes

Compared values

Sector Change 5d. change 1st Jan change 1-year change 5-years change Capi. ST MT LT
Y-MABS THERAPEUTICS, INC.
Bio Therapeutic Drugs
-3.20%-31.44%+73.02%+14.79%-43.81% 535M
Bearish
Bullish
Bullish

Technical Rankings Surperformance

  1. Stock Market
  2. Equities
  3. YMAB Stock
  4. Charts Y-mAbs Therapeutics, Inc.
  5. Comparison Chart